Novo Nordisk, Eli Lilly, Sanofi sued by California over prices
Insulin list prices have increased hundreds of percent over the last two decades – the state of California now sues a number of insulin makers for deceptive overcharging of customers.
By Malathi Nayak, bloomberg
Eli Lilly & Co., Novo Nordisk AS and Sanofi were sued by California over insulin prices, which the state claims are inflated through unfair and deceptive practices and disproportionately affect low-income households and people of color.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
FDA approves new sensor for insulin pens
For subscribers
